Back to UBS Group AG UBS Group AG

RANIRANI
Showing 8 of 19 quarters

Position history for UBS Group AGUBS Group AG's holdings in RANI THERAPEUTICS HLDGS INC

UBS Group AG holds 227,223 shares of RANI (RANI THERAPEUTICS HLDGS INC), worth $167,009 as of 2026-Q1. The position was increased (+50.0% shares).

Current Value

$167,009

Current Shares

227,223

Total Value Change

+$155,609

Total Shares Change

+224,223

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
227,223
+50.0%
$167,0090.0%$1.38
21
2025-Q4
Increased
151,523
+119.2%
$204,5560.0%$1.35
25
2025-Q3
Increased
69,123
+11.4%
$34,5620.0%$0.49
15
2025-Q2
Decreased
62,064
-13.9%
$31,9010.0%$0.55
0
2025-Q1
Increased
72,117
+206.6%
$90,8670.0%$1.36
24
2024-Q4
Increased
23,525
+49.8%
$32,2300.0%$1.48
19
2024-Q3
Increased
15,709
+423.6%
$33,9310.0%$2.16
22
2024-Q2
Unchanged
3,000
0.0%
$11,4000.0%$3.80
0

Other major holders of RANI: RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, Alphabet Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used